GILD · Gilead Sciences, Inc.
Gilead Sciences, Inc. GILD
Develops and sells prescription medicines for HIV, viral hepatitis, and cancer.
- Industry
- Biotechnology
- Listed on
- Nasdaq NMS
- IPO
- 1992-01-22
- Website
- gilead.com
No coverage yet. Updates appear here when Gilead Sciences, Inc. is in the news.
More on Gilead Sciences, Inc.
Earnings
- Q3 2026 earnings · October 29, 2026
This content is for informational purposes only and is not investment advice. Always do your own research before making financial decisions.